Iranian Red Crescent Medical Journal

Published by: Kowsar

Sublingual Versus Oral Captopril for Decreasing Blood Pressure in Hypertension Urgency: A Randomized Clinical Trial

Mehdi Mousavi 1 , * , Nasrin Razavianzadeh 2 , Mania Armin 3 and Maryam Fadaei Dashti 1
Authors Information
1 Shahid Rajaei Educational and Medical Center, Alborz University of Medical Sciences, Karaj, Iran
2 Department of Medical Sciences, Islamic Azad University, Shahrood Branch, Shahrood, Iran
3 Islamic Azad University Shahrood Branch, Shahrood, Iran
Article information
  • Iranian Red Crescent Medical Journal: June 2018, 20 (6); e61606
  • Published Online: May 27, 2018
  • Article Type: Research Article
  • Received: September 11, 2017
  • Revised: December 6, 2017
  • Accepted: December 21, 2017
  • DOI: 10.5812/ircmj.61606

To Cite: Mousavi M, Razavianzadeh N, Armin M, Fadaei Dashti M. Sublingual Versus Oral Captopril for Decreasing Blood Pressure in Hypertension Urgency: A Randomized Clinical Trial, Iran Red Crescent Med J. 2018 ; 20(6):e61606. doi: 10.5812/ircmj.61606.

Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Ronald G, Victor RG. Systemic Hypertension: Mechanisms and Diagnosis. In: Mann DL, Braunwald E, editors. Braunwald's heart disease : a textbook of cardiovascular medicine. Philadelphia, Pa: Elsevier, Saunders; 2015. p. 934-52.
  • 2. Kotchen T. Hypertensive vascular disease. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J, editors. Harrison's principles of internal medicine. New York: McGraw-Hi11 Education; 2015. p. 1611-27.
  • 3. Ronald G, Victor RG, Libby P. Systemic Hypertension: Management. In: Mann DL, Braunwald E, editors. Braunwald's heart disease : a textbook of cardiovascular medicine. Philadelphia, Pa: Elsevier, Saunders; 2015. p. 953-96.
  • 4. Ipek E, Oktay AA, Krim SR. Hypertensive crisis: an update on clinical approach and management. Curr Opin Cardiol. 2017;32(4):397-406. doi: 10.1097/HCO.0000000000000398. [PubMed: 28306673].
  • 5. Marik PE, Varon J. Hypertensive crises: challenges and management. Chest. 2007;131(6):1949-62. doi: 10.1378/chest.06-2490. [PubMed: 17565029].
  • 6. Varon J, Marik PE. The diagnosis and management of hypertensive crises. Chest. 2000;118(1):214-27. doi: 10.1378/chest.118.1.214. [PubMed: 10893382].
  • 7. Karakilic E, Buyukcam F, Kocalar G, Gedik S, Atalar E. Same effect of sublingual and oral captopril in hypertensive crisis. Eur Rev Med Pharmacol Sci. 2012;16(12):1642-5. [PubMed: 23161035].
  • 8. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-20. doi: 10.1001/jama.2013.284427. [PubMed: 24352797].
  • 9. Sweetman SC. Martindale : the complete drug reference. London; Chicago: Pharmaceutical Press; 2009.
  • 10. Kaya A, Tatlisu MA, Kaplan Kaya T, Yildirimturk O, Gungor B, Karatas B, et al. Sublingual vs. Oral Captopril in Hypertensive Crisis. J Emerg Med. 2016;50(1):108-15. doi: 10.1016/j.jemermed.2015.07.017. [PubMed: 26409670].
  • 11. Kazerani H, Hajimoradi B, Amini A, Naseri MH, Moharamzad Y. Clinical efficacy of sublingual captopril in the treatment of hypertensive urgency. Singapore Med J. 2009;50(4):400-2. [PubMed: 19421685].
  • 12. Gemici K, Karakoc Y, Ersoy A, Baran II, Gullulu S, Cordan J. A Comparison of Safety and Efficacy of Sublingual Captopril with Sublingual Nifedipine in Hypertensive Crisis. Int J Angiol. 1999;8(3):147-9. doi: 10.1007/BF01616442. [PubMed: 10387121].
  • 13. Wu SG, Lin SL, Shiao WY, Huang HW, Lin CF, Yang YH. Comparison of sublingual captopril, nifedipine and prazosin in hypertensive emergencies during hemodialysis. Nephron. 1993;65(2):284-7. doi: 10.1159/000187489. [PubMed: 8247194].
  • 14. Dessi-Fulgheri P, Bandiera F, Rubattu S, Cocco F, Madeddu P, Oppes M, et al. Comparison of sublingual and oral captopril in hypertension. Clin Exp Hypertens A. 1987;9(2-3):593-7. doi: 10.3109/10641968709164229. [PubMed: 3038422].
  • 15. Longhini C, Ansani L, Musacci G, Mele D, Vaccari M, Baracca E, et al. The effect of captopril on peripheral hemodynamics in patients with essential hypertension: comparison between oral and sublingual administration. Cardiovasc Drugs Ther. 1990;4(3):751-4. doi: 10.1007/BF01856565. [PubMed: 2076385].
  • 16. Alletto M, Burgio A, Fulco G, Paradiso R, Piangiamore M, Vancheri F. [Sublingual captopril in hypertensive crises]. Recenti Prog Med. 1992;83(9):503-5. [PubMed: 1439119].
  • 17. Sulbaran T, Aparicio J, Bermudez G. [The use of sublingual captopril in hypertensive crises]. Invest Clin. 1994;35(3):143-54. [PubMed: 7803550].
  • 18. Ceyhan B, Karaaslan Y, Caymaz O, Oto A, Oram E, Oram A, et al. Comparison of sublingual captopril and sublingual nifedipine in hypertensive emergencies. Jpn J Pharmacol. 1990;52(2):189-93. doi: 10.1254/jjp.52.189. [PubMed: 2179605].
  • 19. Guerrera G, Melina D, Capaldi L, Mauro R, Colivicchi F, Cardillo C, et al. [Sublingually administered captopril versus nifedipine in hypertension emergencies]. Minerva Cardioangiol. 1990;38(1-2):37-44. [PubMed: 2188165].
  • 20. Perez C, Dougnac A, Alvarez M, Andresen M, Diaz O, Geni R, et al. [Sublingual captopril versus nifedipine in the treatment of hypertensive crisis]. Rev Med Chil. 1991;119(4):402-5. [PubMed: 1842983].
  • 21. Angeli P, Chiesa M, Caregaro L, Merkel C, Sacerdoti D, Rondana M, et al. Comparison of sublingual captopril and nifedipine in immediate treatment of hypertensive emergencies. A randomized, single-blind clinical trial. Arch Intern Med. 1991;151(4):678-82. doi: 10.1001/archinte.151.4.678. [PubMed: 2012448].
  • 22. Salkic S, Brkic S, Batic-Mujanovic O, Ljuca F, Karabasic A, Mustafic S. Emergency Room Treatment of Hypertensive Crises. Med Arch. 2015;69(5):302-6. doi: 10.5455/medarh.2015.69.302-306. [PubMed: 26622081]. [PubMed Central: PMC4639340].
  • 23. Sruamsiri K, Chenthanakij B, Wittayachamnankul B. Management of patients with severe hypertension in emergency department, Maharaj Nakorn Chiang Mai hospital. J Med Assoc Thai. 2014;97(9):917-22. [PubMed: 25536708].
  • 24. Brayfield A. Martindale : the complete drug reference. 2017.
  • 25. al-Furaih TA, McElnay JC, Elborn JS, Rusk R, Scott MG, McMahon J, et al. Sublingual captopril--a pharmacokinetic and pharmacodynamic evaluation. Eur J Clin Pharmacol. 1991;40(4):393-8. doi: 10.1007/BF00265850. [PubMed: 2050174].
  • 26. Maleki A, Sadeghi M, Zaman M, Tarrahi MJ, Nabatchi B. Nifedipine, Captopril or Sublingual Nitroglycerin, Which can Reduce Blood Pressure the Most? ARYA Atheroscler. 2011;7(3):102-5. [PubMed: 22577455]. [PubMed Central: PMC3347854].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments